Myriad Genetics, Inc. MYGN
NASDAQ · United States · Health Technology
$4.54+0.48 (+11.82%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-30 | -0.25 | -0.06 | -332.7% | $190.70M | -7.4% | -43.3%$5.04→$2.86 |
| Q1 2026 | 2026-05-05 | -0.16 | -0.16 | 0.0% | — | — | -16.8% |
| Q4 2025 | 2026-02-23 | 0.04 | -0.02 | +300.0% | — | — | +3.3%$4.29→$4.43 |
| Q3 2025 | 2025-11-03 | 0.00 | -0.01 | +100.0% | — | — | -19.7%$8.04→$6.46 |
| Q4 2024 | 2025-02-24 | 0.03 | 0.03 | 0.0% | — | — | — |
| Q3 2023 | 2023-11-06 | -0.03 | -0.08 | +62.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.